Kanglaite Injection Phase I Study

Clinical trial NCT00031031 · COMPLETED

Trial details

NCT number: NCT00031031
Sponsor: KangLaiTe USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Refractory To Standard Therapy Neoplasms

Start date: 2001-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.